基于综合分析的基础上,确定斑块脆弱性的潜在治疗点
Liu Miao1, Yue-Ai Qin1, Zhi-Jie Yang1
1Department of Cardiology, Liuzhou People's Hospital, Affiliated of Guangxi Medical University, 8 Wenchang Road, Liuzhou 545006, Guangxi, China; The Key Laboratory of Coronary Atherosclerotic Disease Prevention and Treatment of Liuzhou, China.
概括
这项研究确定了GZMA和GZMB作为关键基因,与急性冠状动脉综合征 (ACS) 中的斑块脆弱性相关. 这些发现表明GZMA和GZMB是预防ACS的潜在治疗点.
科学领域:
- 基因组学就是基因组学.
- 心血管研究研究心血管研究
- 生物信息学是一种生物信息学.
背景情况:
- 动脉样硬化斑块的脆弱性是急性冠状动脉综合征 (ACS) 的关键因素.
- 识别用于斑块稳定的分子标对于ACS预防至关重要.
研究的目的:
- 确定与斑块脆弱性相关的枢纽基因和途径.
- 探索急性冠状动脉综合征 (ACS) 的潜在治疗点.
主要方法:
- 分析了四个基因表达综合 (GEO) 微阵列数据集.
- 利用差异表达基因 (DEGs),加权基因协同表达网络 (WGCNA) 和免疫细胞透分析 (IIA).
- 基因和基因组的应用京都百科全书 (KEGG) 路径丰富,基因本体学 (GO) 注释和蛋白质-蛋白质相互作用 (PPI) 网络分析用于枢纽基因识别. 使用随机森林和人工神经网络进行验证. 通过CMap和Herb数据库进行治疗查.
主要成果:
- 在GSE62646.6中鉴定了168个DEG和1974个IIA基因.
- 在功能分析后发现了114个枢纽基因,其中有6个丰富的KEGG通路.
- 验证的GZMA,GZMB,KLRB1,KLRD1和TRPM6;GZMA和GZMB被确定为治疗点.
结论:
- GZMA和GZMB已被验证为治疗斑块脆弱性的治疗标.
- 这项研究为ACS预防提供了潜在的治疗策略.
- 需要进一步的实验验证,以确认GZMA和GZMB是ACS的基于血液的预测因素.
更多相关视频
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
521
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
521
Clot Retraction and Fibrinolysis
5.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.6K
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
686
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
686
Formation of the Platelet Plug
5.9K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.9K


